Immunogenic Compositions for SARS-CoV-2 Vaccines Using MHC Class II Peptides

Fri, 10 Apr 2026 02:46:17 +0000
Intellectual Property

USPTO published patent application US20260097115A1 for immunogenic compositions containing MHC class II-binding peptides derived from SARS-CoV-2 translation products. The application covers vaccine compositions and methods for treating and preventing COVID-19. Inventors include researchers from Broad Institute and affiliated institutions.